Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Sales (2018 - 2026)

10x Genomics' Return on Sales history spans 8 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q4 2025 for 10x Genomics, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for TXG hit a ceiling of 0.0% in Q2 2025 and a floor of 0.01% in Q3 2023.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
  • The widest YoY moves for Return on Sales: up 4bps in 2021, down 0bps in 2021.
  • Tracing TXG's Return on Sales over 5 years: stood at 0.0% in 2021, then grew by 14bps to 0.0% in 2022, then tumbled by -141bps to 0.0% in 2023, then fell by -12bps to 0.0% in 2024, then skyrocketed by 67bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for TXG at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.